Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus

Reference

• aan het Rot M, Collins KA, Fitterling HL. 2009. Physical exercise and depression. Mt Sinai J Med 76(2):204–214.
   Google Scholar
• Baltus GA, Kowalski MP, Tutter AV, Kadam S. 2009. A positive regulatory role for the mSin3A-HDAC complex in pluri potency through Nanog and Sox2. J Biol Chem 284(11): 6998–7006.
   Google Scholar
• Berton O, Nestler EJ. 2006. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7(2): 137–151.
   Google Scholar
• Boffa LC, Vidali G, Mann RS, Allfrey VG. 1978. Suppression of histone deacetylation in vivo and in vitro by sodium butyrate. J Biol Chem 253(10):3364–3366.
   Google Scholar
• Canitano A, Papa M, Boscia F, Castaldo P, Sellitti S, Taglialatela M, . 2002. Brain distribution of the Na+/Ca2+ exchanger-encoding genes NCX1, NCX2, and NCX3 and their related proteins in the central nervous system. Ann NY Acad Sci 976: 394–404.
   Google Scholar
• Celada P, Puig M, Amargos-Bosch M, Adell A, Artigas F. 2004. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29(4):252–265.
   Google Scholar
• Davis PJ, Spaulding SW, Gregerman RI. 1970. The three thyr oxine-binding proteins in rat serum: binding capacities and effects of binding inhibitors. Endocrinology 87(5):978–986.
   Google Scholar
• De Luca V, Tharmalingam S, Kennedy JL. 2007. Association study between the corticotropin-releasing hormone receptor 2 gene and suicidality in bipolar disorder. Eur Psychiatry 22(5): 282–287.
   Google Scholar
• Dokmanovic M, Marks PA. 2005. Prospects: histone deacetylase inhibitors. J Cell Biochem 96(2):293–304.
   Google Scholar
• Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59(12):1116–1127.
   PubMed Web of Science ®Google Scholar
• Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ. 2009. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord 116(1–2):4–11.
   Google Scholar
• Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, . 2003. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23(28):9418–9427.
   Google Scholar
• Fuchikami M, Morinobu S, Kurata A, Yamamoto S, Yamawaki S. 2009. Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int J Neuropsychopharmacol 12(1):73–82.
   PubMed Web of Science ®Google Scholar
• Fung WP, Thomas T, Dickson PW, Aldred AR, Milland J, Dziadek M, . 1988. Structure and expression of the rat transthyretin (prealbumin) gene. J Biol Chem 263(1):480–488.
   Google Scholar
• Gabellini N. 2004. Transcriptional regulation by cAMP and Ca2+links the Na+/Ca2+ exchanger 3 to memory and sensory pathways. Mol Neurobiol 30(1):91–116.
   Google Scholar
• Gomez E, Catalan R, Navines R, Gasto C. 2001. [Serotonin receptor changes in depression: evidences and limitations]. Actas Esp Psiquiatr 29(3):186–194.
   Google Scholar
• Gray JA, Roth BL. 2001. Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists. Brain Res Bull 56(5):441–451.
   Google Scholar
• Gregus A, Wintink AJ, Davis AC, Kalynchuk LE. 2005. Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behav Brain Res 156(1):105–114.
   Google Scholar
• Gundersen BB, Blendy JA. 2009. Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety. Neuropharmacology 57(1):67–74.
   Google Scholar
• Hagen GA, Elliott WJ. 1973. Transport of thyroid hormones in serum and cerebrospinal fluid. J Clin Endocrinol Metab 37(3):415–422.
   Google Scholar
• Jin K, Mao XO, Simon RP, Greenberg DA. 2001. Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia. J Mol Neurosci 16(1):49–56.
   Google Scholar
• Kadota K, Nakai Y, Shimizu K. 2008. A weighted average difference method for detecting differentially expressed genes from microarray data. Algorithms Mol Biol 3:8.
   Google Scholar
• Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM. 2007. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321(3):892–901.
   Google Scholar
• Kim HJ, Leeds P, Chuang DM. 2009. The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem 110(4):1226–1240.
   Google Scholar
• Kohda K, Jinde S, Iwamoto K, Bundo M, Kato N, Kato T. 2006. Maternal separation stress drastically decreases expression of transthyretin in the brains of adult rat offspring. Int J Neuro psychopharmacol 9(2):201–208.
   Google Scholar
• Kramer OH, Gottlicher M, Heinzel T. 2001. Histone deacetylase as a therapeutic target. Trends Endocrinol Metab 12(7):294–300.
   Google Scholar
• Little A. 2009. Treatment-resistant depression. Am Fam Physician 80(2):167–172.
   Google Scholar
• Marks PA, Richon VM, Rifkind RA. 2000. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92(15):1210–1216.
   Google Scholar
• Marks W, Fournier NM, Kalynchuk LE. 2009. Repeated exposure to corticosterone increases depression-like behavior in two different versions of the forced swim test without altering nonspecific locomotor activity or muscle strength. Physiol Behav 98(1–2):67–72.
   Google Scholar
• Mathew SJ. 2008. Treatment-resistant depression: recent developments and future directions. Depress Anxiety 25(12):989–992.
   Google Scholar
• Minamiyama M, Katsuno M, Adachi H, Waza M, Sang C, Kobayashi Y, . 2004. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 13(11):1183–1192.
   Google Scholar
• Mintun MA, Sheline YI, Moerlein SM, Vlassenko AG, Huang Y, Snyder AZ. 2004. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biol Psychiatry 55(3):217–224.
   Google Scholar
• Nucifora FC, Jr., Sasaki M, Peters MF, Huang H, Cooper JK, Yamada M, . 2001. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291(5512):2423–2428.
   Google Scholar
• Rascle A, Johnston JA, Amati B. 2003. Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol Cell Biol 23(12):4162–4173.
   PubMed Web of Science ®Google Scholar
• Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL. 2003. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J 22(24):6537–6549.
   Google Scholar
• Saha RN, Pahan K. 2006. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 13(4):539–550.
   Google Scholar
• Schramm NL, McDonald MP, Limbird LE. 2001. The alpha(2a)-adrenergic receptor plays a protective role in mouse beha vioral models of depression and anxiety. J Neurosci 21(13): 4875–4882.
   Google Scholar
• Schreiber G. 2002. The evolution of transthyretin synthesis in the choroid plexus. Clin Chem Lab Med 40(12):1200–1210.
   Google Scholar
• Schroeder FA, Lin CL, Crusio WE, Akbarian S. 2007. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62(1): 55–64.
   Google Scholar
• Schroeder FA, Penta KL, Matevossian A, Jones SR, Konradi C, Tapper AR, . 2008. Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacology 33(12):2981–2992.
   Google Scholar
• Sheline YI, Mintun MA, Barch DM, Wilkins C, Snyder AZ, Moerlein SM. 2004. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography. Neuropsychopharmacology 29(12): 2235–2241.
   Google Scholar
• Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berlin) 85(3):367–370.
   Google Scholar
• Sullivan GM, Mann JJ, Oquendo MA, Lo ES, Cooper TB, Gorman JM. 2006. Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function. Biol Psychiatry 60(5):500–506.
   Google Scholar
• Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. 2006. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9(4):519–525.
   PubMed Web of Science ®Google Scholar
• Tsankova N, Renthal W, Kumar A, Nestler EJ. 2007. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8(5): 355–367.
   PubMedGoogle Scholar
• Uittenbogaard M, Chiaramello A. 2002. Expression of the bHLH transcription factor Tcf12 (ME1) gene is linked to the expansion of precursor cell populations during neurogenesis. Brain Res Gene Expr Patterns 1(2):115–121.
   Google Scholar
• Umathe SN, Bhutada PS, Jain NS, Shukla NR, Mundhada YR, Dixit PV. 2008. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice. Neuropeptides 42(4): 399–410.
   Google Scholar
• Van Lint C, Emiliani S, Verdin E. 1996. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5(4–5):245–253.
   PubMed Web of Science ®Google Scholar
• Wang LG, Ossowski L, Ferrari AC. 2004. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line. Oncogene 23(30):5175–5184.
   PubMed Web of Science ®Google Scholar
• Xu WS, Parmigiani RB, Marks PA. 2007. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26(37):5541–5552.
   PubMedGoogle Scholar
• Xu Z, Hou B, Zhang Y, Gao Y, Wu Y, Zhao S, . 2009. Antidepressive behaviors induced byenriched environment might be modulated by glucocorticoid levels. Eur Neuropsycho pharmacol 19(12):868–875.
   Google Scholar
• Ying M, Xu R, Wu X, Zhu H, Zhuang Y, Han M, . 2006. Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA. J Biol Chem 281(18):12580–12586.
   Google Scholar